Form 4: STERIS CFO Michael Tokich Reports Routine Stock Vesting and Tax Withholding

STERIS plc's Senior Vice President and CFO, Michael J. Tokich, reported the vesting of 1,141 restricted shares and the subsequent withholding of 341 shares for tax obligations on June 4, 2025.

Summary

• Michael J. Tokich, STERIS plc's Senior Vice President and Chief Financial Officer, reported a change in his beneficial ownership of the company's ordinary shares.
• On June 4, 2025, 1,141 restricted shares, which were awarded on June 4, 2024, vested.
• Of these vested shares, 341 ordinary shares were withheld by the Issuer at a price of $242.1 per share to cover tax obligations as required by applicable employment or tax laws.
• Following this transaction, Mr. Tokich directly beneficially owns 43,891 ordinary shares, of which 6,506 are restricted and subject to future vesting schedules.
• Additionally, Mr. Tokich indirectly holds 3,592 ordinary share equivalents through the STERIS Corporation 401(k) Plan as of June 2, 2025.

Sentiment

Score: 7

Explanation: The filing indicates a routine, expected transaction related to executive compensation. The vesting of shares is generally positive as it reflects long-term incentive plan execution, and the disposition is solely for tax purposes, not a discretionary sale, which is neutral to slightly positive for investor sentiment.

Positives

• The vesting of restricted shares indicates the fulfillment of long-term incentive compensation for the CFO.
• The transaction is a routine tax-related withholding, not a discretionary sale by the insider.

Negatives

• 341 shares were disposed of to cover tax liabilities, reducing the direct share count by that amount.

Risks

• No specific risks are mentioned in this Form 4 filing, as it primarily reports a routine insider transaction.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook, as its purpose is solely to report changes in insider beneficial ownership.

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive analysis for the healthcare or medical device industry in which STERIS plc operates.

Comparison to Industry Standards

• This document reports a standard insider transaction (restricted stock vesting and tax withholding) which is common across all industries for executive compensation. There are no specific comparable companies, projects, or results mentioned to assess against industry standards.

Stakeholder Impact

• Shareholders: The transaction is a routine part of executive compensation and does not indicate a change in company strategy or financial health. The withholding of shares for taxes is a common practice and not a discretionary sale.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• Future vesting of 6,506 restricted ordinary shares held directly by Mr. Tokich on various dates between October 1, 2025, and June 5, 2028.

Key Dates

Recommendation

Keywords

STERIS plc, STE, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Michael J. Tokich, CFO